系统性硬化症门诊患者的幸福感疗法:一项随机对照试验
一项随机对照试验将32例系统性硬化症门诊患者按1:1随机分为幸福感疗法组(WBT,n=16)与常规治疗组(TAU,n=16),主要结局为幸福感。与TAU相比,WBT在主观幸福感(P≤0.001)、个人成长(P=0.006)、自我接纳(P=0.003)方面显著改善,心理困扰(P=0.010)、精神痛苦(P=0.010)、受苦感(P≤0.001)下降更明显;主观幸福感在T3(7个月)仍维持(P=0.012),受苦感在T4(10个月)仍维持(P≤0.001)。作者认为结果为WBT作为短期方法的初步证据,需更大样本研究才能推荐WBT。
要点
- WBT组主观幸福感、个人成长、自我接纳较TAU组显著改善(P≤0.001、P=0.006、P=0.003)。
- WBT组心理困扰(P=0.010)、精神痛苦(P=0.010)、受苦感(P≤0.001)较TAU组下降更明显。
- 主观幸福感改善维持至T3(P=0.012),受苦感改善维持至T4(P≤0.001)。
核心结论
- WBT在系统性硬化症门诊患者中显示出短期获益的初步证据,但需更大样本研究才能推荐WBT用于系统性硬化症患者。
研究设计与样本
- 随机对照试验,32例系统性硬化症门诊患者按1:1随机分为WBT组(n=16)与常规治疗(TAU,即常规医学检查)组(n=16)。
- 主要结局为幸福感;次要结局包括与系统性硬化症相关的功能能力、心理困扰、精神痛苦、受苦感。
- 所有受试者在基线(T0)评估;WBT组于2个月(WBT第4次会谈结束,T1)、4个月(第8次会谈结束,T2)、7个月(3个月随访,T3)、10个月(6个月随访,T4)评估;TAU组于基线后2、4、7、10个月评估。
主要发现
- 与TAU相比,WBT使主观幸福感(P≤0.001)、个人成长(P=0.006)、自我接纳(P=0.003)显著改善,主观幸福感改善维持至T3(P=0.012)。
- 与TAU相比,WBT使心理困扰(P=0.010)、精神痛苦(P=0.010)、受苦感(P≤0.001)下降更明显,受苦感改善维持至T4(P≤0.001)。
- 参与者对WBT报告了高满意度。
临床怎么用
- 作者认为WBT可作为住院和门诊系统性硬化症医疗路径的短期方法(初步证据),但需更大样本研究才能推荐WBT用于系统性硬化症患者。
局限性
- 原文结论指出需更大样本研究才能获得推荐WBT用于系统性硬化症患者的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Systemic sclerosis (SSc) patients have psychological distress and poor well-being and need a tailored treatment. Psychological interventions, rarely tested for efficacy, showed poor benefits. The present randomized controlled trial tested the efficacy of Well-Being Therapy (WBT) in SSc patients. METHODS: Thirty-two outpatients were randomized (1:1) to WBT (n = 16) or Treatment As Usual (i.e. routine medical check-ups) (TAU) (n = 16). Primary outcome was well-being. Secondary outcomes included functional ability related to SSc, psychological distress, mental pain, suffering. All participants were assessed at baseline (T0). The WBT group was assessed after two months (end of WBT session 4) (T1), after four months (end of WBT session 8) (T2), after seven months (3-month follow-up) (T3) and after 10 months (6-month follow-up) (T4). The TAU group was assessed two (T1), four (T2), seven (T3) and ten (T4) months after baseline. RESULTS: WBT produced a significant improvement in subjective well-being (P ≤ 0.001), personal growth (P = 0.006), self-acceptance (P = 0.003) compared with TAU, maintained at T3 as what concerns subjective well-being (P = 0.012). WBT produced a greater decrease in psychological distress (P = 0.010), mental pain (P = 0.010), suffering (P ≤ 0.001) compared with TAU, maintained at T4 as what concerns suffering (P ≤ 0.001). Participants reported high satisfaction with WBT. CONCLUSION: The study provides preliminary evidence on the benefits of WBT as short-term approach for in- and out-patient SSc healthcare paths. Studies with larger samples are needed to have the evidence for recommending WBT to SSc patients.
引用
- Romanazzo S, Ceccatelli S, Mansueto G, et al. Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial. Rheumatology (Oxford). 2025. PMID: 38366929. doi:10.1093/rheumatology/keae114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。